Cytori Therapeutics, Inc. Publishes Review On Potential Of Adipose Stem Cells To Treat Cardiovascular Disease In Nature Clinical Practice

SAN DIEGO--(BUSINESS WIRE)--March 1, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX)(Frankfurt:XMPA) announced today the publication of a summary of peer-reviewed research, authored by Cytori scientists, on the potential of adipose stem cells in cardiac cell therapy. The article, titled “Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes,” appears in the Cardiovascular Medicine Supplement of Nature Clinical Practice, March 3, 2006, Volume 3, Supplement 1, and is available online this week (www.nature.com/clinicalpractice).

MORE ON THIS TOPIC